Marrying the Business with the Science
Update: 2025-10-15
Description
Sam Kulkarni, PhD, CEO and Chairman of CRISPR Therapeutics, joins Venrock’s Nimish Shah for a conversation about how they’re using gene editing to find potential cures so miraculous, it almost sounds like science fiction. Sam shares advice on how to fundraise in the extraordinarily capital-intensive biotech market, having the courage to go after difficult things and face detractors, and how CEOs should find opportunity in volatility.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
